首页 > 最新文献

SAGE Open Medicine最新文献

英文 中文
Protective effect of bone marrow mesenchymal stem cells on the survival zone of the perforator flaps in rats. 骨髓间充质干细胞对大鼠穿孔器皮瓣存活区的保护作用。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-06 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241276278
Fatemeh Bazgir, Arian Karimi Rouzbahani, Mehdi Birjandi, Farzaneh Chehelcheraghi

Background: Perforator flaps have recently been used in the field of plastic surgery. Skin defects can be reconstructed to reach functional and cosmetic goals. With the development of reconstructive approaches, utilizing stem cells is a hopeful approach to enhance wound healing and tissue recovery. In this study, we assessed the effect of bone marrow mesenchymal stem cells on the perforator flap's survival in rats.

Methods: Perforator flaps (2.5 × 11 cm) were transplanted into rats and focused on the thoracodorsal, intercostal, and deep circumflex arteries, which were randomly divided into three groups: control, saline, and bone marrow mesenchymal stem cells (7 × 106 ml). Seven days after the surgery, tissue edema, inflammation, and discharge were observed and photographed. Histological analyses were performed to determine flap survival. Hematoxylin and eosin staining was performed to assess levels of microvascular density determined in skin flaps.

Results: Rats in the bone marrow mesenchymal stem cells group exhibited higher average flap survival area, and higher microvascular density levels at the dynamical regions of the flaps compared with the other two groups. Subdermal injection of bone marrow mesenchymal stem cells significantly increased ischemic perforator flap survival due to stimulated neovascularization in rats.

Conclusion: Our findings suggest the potential usefulness of bone marrow mesenchymal stem cells in preventing skin flap perforator tissue necrosis.

背景:打孔器皮瓣最近被用于整形外科领域。皮肤缺损可通过重建达到功能和美容目的。随着重建方法的发展,利用干细胞来促进伤口愈合和组织恢复是一种充满希望的方法。在这项研究中,我们评估了骨髓间充质干细胞对大鼠穿孔皮瓣存活的影响:方法:将穿孔器皮瓣(2.5 × 11 厘米)移植到大鼠体内,并将其集中于胸背、肋间和深周动脉,随机分为三组:对照组、生理盐水组和骨髓间充质干细胞组(7 × 106 ml)。术后七天,对组织水肿、炎症和分泌物进行观察和拍照。进行组织学分析以确定皮瓣存活率。进行血红素和伊红染色以评估皮瓣中微血管密度的水平:结果:与其他两组相比,骨髓间充质干细胞组大鼠的皮瓣平均存活面积更高,皮瓣动态区域的微血管密度水平更高。骨髓间充质干细胞皮下注射可显著提高大鼠缺血穿孔皮瓣的存活率,这是因为骨髓间充质干细胞刺激了血管新生:我们的研究结果表明,骨髓间充质干细胞在预防皮瓣穿孔组织坏死方面具有潜在的作用。
{"title":"Protective effect of bone marrow mesenchymal stem cells on the survival zone of the perforator flaps in rats.","authors":"Fatemeh Bazgir, Arian Karimi Rouzbahani, Mehdi Birjandi, Farzaneh Chehelcheraghi","doi":"10.1177/20503121241276278","DOIUrl":"https://doi.org/10.1177/20503121241276278","url":null,"abstract":"<p><strong>Background: </strong>Perforator flaps have recently been used in the field of plastic surgery. Skin defects can be reconstructed to reach functional and cosmetic goals. With the development of reconstructive approaches, utilizing stem cells is a hopeful approach to enhance wound healing and tissue recovery. In this study, we assessed the effect of bone marrow mesenchymal stem cells on the perforator flap's survival in rats.</p><p><strong>Methods: </strong>Perforator flaps (2.5 × 11 cm) were transplanted into rats and focused on the thoracodorsal, intercostal, and deep circumflex arteries, which were randomly divided into three groups: control, saline, and bone marrow mesenchymal stem cells (7 × 10<sup>6</sup> ml). Seven days after the surgery, tissue edema, inflammation, and discharge were observed and photographed. Histological analyses were performed to determine flap survival. Hematoxylin and eosin staining was performed to assess levels of microvascular density determined in skin flaps.</p><p><strong>Results: </strong>Rats in the bone marrow mesenchymal stem cells group exhibited higher average flap survival area, and higher microvascular density levels at the dynamical regions of the flaps compared with the other two groups. Subdermal injection of bone marrow mesenchymal stem cells significantly increased ischemic perforator flap survival due to stimulated neovascularization in rats.</p><p><strong>Conclusion: </strong>Our findings suggest the potential usefulness of bone marrow mesenchymal stem cells in preventing skin flap perforator tissue necrosis.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the presence of Helicobacter pylori and the development of de novo anemia in adults undergoing sleeve gastrectomy. 接受袖状胃切除术的成人中幽门螺杆菌的存在与新生贫血的发生之间的关系。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275340
Tammy S Carrillo-Levin, Maria F Jaramillo-Ocharan, Gustavo Salinas-Sedo, Carlos J Toro-Huamanchumo

Background: Sleeve gastrectomy has gained prominence in obesity treatment, yet it is not without complications, such as the development of anemia in the medium term. Given the high prevalence of Helicobacter pylori infection in Peru, it is imperative to explore its potential association with this postoperative complication.

Objective: To evaluate the association between the presence of Helicobacter pylori and the development of anemia 12 months after sleeve gastrectomy.

Methods: A retrospective cohort study was carried out based on an analysis of secondary data from a private clinic in Lima, Peru, which included two groups of people over 18 years of age who had undergone sleeve gastrectomy between 2010 and 2020. We considered the subjects who had the previous diagnosis of Helicobacter pylori as well as those who did not have the infection, according to the detection of the bacteria by endoscopy before surgery.

Results: A total 313 individuals were analyzed, and it was found that the prevalence of Helicobacter pylori was 46.0% and the incidence of anemia 12 months after sleeve gastrectomy was 18.2%. The presence of Helicobacter pylori increased the risk of de novo anemia (Relative Risk = 1.56; 95% confidence intervals: 1.02-2.41; p = 0.043). When stratifying by sex, the association was maintained only for the male group (Relative Risk = 2.84; 95% confidence intervals: 1.02-7.02; p = 0.047).

Conclusions: It was identified that the presence of Helicobacter pylori had a significant association with the development of de novo anemia, mainly in male subjects, 1 year after undergoing sleeve gastrectomy.

背景:袖带胃切除术在肥胖症治疗中的地位日益突出,但也并非没有并发症,如中期贫血。鉴于幽门螺杆菌感染在秘鲁的高发率,探讨其与这种术后并发症的潜在关联势在必行:目的:评估幽门螺杆菌的存在与袖状胃切除术后 12 个月出现贫血之间的关系:我们对秘鲁利马一家私人诊所的二手数据进行了分析,并在此基础上开展了一项回顾性队列研究,研究对象包括两组在 2010 年至 2020 年间接受过袖状胃切除术的 18 岁以上人群。根据手术前内镜检查发现幽门螺杆菌的情况,我们考虑了先前诊断出幽门螺杆菌感染的受试者和未感染幽门螺杆菌的受试者:共对 313 人进行了分析,结果发现幽门螺杆菌的感染率为 46.0%,袖状胃切除术后 12 个月贫血的发生率为 18.2%。幽门螺杆菌的存在增加了新发贫血的风险(相对风险 = 1.56;95% 置信区间:1.02-2.41;P = 0.043)。按性别分层时,只有男性组保持这种关联(相对风险 = 2.84;95% 置信区间:1.02-7.02;P = 0.047):结论:研究发现,幽门螺杆菌的存在与新发贫血的发生有显著关联,主要发生在接受袖带胃切除术一年后的男性受试者中。
{"title":"Association between the presence of <i>Helicobacter pylori</i> and the development of de novo anemia in adults undergoing sleeve gastrectomy.","authors":"Tammy S Carrillo-Levin, Maria F Jaramillo-Ocharan, Gustavo Salinas-Sedo, Carlos J Toro-Huamanchumo","doi":"10.1177/20503121241275340","DOIUrl":"10.1177/20503121241275340","url":null,"abstract":"<p><strong>Background: </strong>Sleeve gastrectomy has gained prominence in obesity treatment, yet it is not without complications, such as the development of anemia in the medium term. Given the high prevalence of <i>Helicobacter pylori</i> infection in Peru, it is imperative to explore its potential association with this postoperative complication.</p><p><strong>Objective: </strong>To evaluate the association between the presence of <i>Helicobacter pylori</i> and the development of anemia 12 months after sleeve gastrectomy.</p><p><strong>Methods: </strong>A retrospective cohort study was carried out based on an analysis of secondary data from a private clinic in Lima, Peru, which included two groups of people over 18 years of age who had undergone sleeve gastrectomy between 2010 and 2020. We considered the subjects who had the previous diagnosis of <i>Helicobacter pylori</i> as well as those who did not have the infection, according to the detection of the bacteria by endoscopy before surgery.</p><p><strong>Results: </strong>A total 313 individuals were analyzed, and it was found that the prevalence of <i>Helicobacter pylori</i> was 46.0% and the incidence of anemia 12 months after sleeve gastrectomy was 18.2%. The presence of <i>Helicobacter pylori</i> increased the risk of de novo anemia (Relative Risk = 1.56; 95% confidence intervals: 1.02-2.41; <i>p</i> = 0.043). When stratifying by sex, the association was maintained only for the male group (Relative Risk = 2.84; 95% confidence intervals: 1.02-7.02; <i>p</i> = 0.047).</p><p><strong>Conclusions: </strong>It was identified that the presence of <i>Helicobacter pylori</i> had a significant association with the development of de novo anemia, mainly in male subjects, 1 year after undergoing sleeve gastrectomy.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review on factors influencing Middle Eastern women's utilization of healthcare services: The promise of mHealth. 中东妇女利用医疗保健服务的影响因素系统回顾:移动医疗的前景。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241276678
Mohsen Khosravi, Seyyed Morteza Mojtabaeian, Mina Aghamaleki Sarvestani

Objectives: The 2030 Sustainable Development Agenda stresses a feminist approach for healthcare services. Cultural and religious influences impact utilization of healthcare services by Muslim women within the Middle East, posing unique challenges. This paper aimed to investigate the factors influencing Middle Eastern women's utilization of healthcare services within the region.

Methods: In the year 2024, a systematic review was conducted. PubMed, Scopus, ProQuest, and the Cochrane Database of Systematic Reviews were searched for this purpose. The quality of the included articles was assessed using the Accuracy, Coverage, Objectivity, Date, Significance (ACODS) checklist. Subsequently, the Joffe method of thematic analysis was employed to analyze the data obtained from the review.

Results: A final selection comprising 59 studies was made for inclusion in the research. The studies demonstrated a high level of quality, and the risk of bias within them was deemed acceptable. The thematic analysis revealed seven principal themes, which encompassed Demographic Factors, Level of Education and Awareness, Sources of Information, Risk Factors, Personal Factors, Level of Service Access and Quality, and Organizational Factors.

Conclusions: This study highlighted key factors influencing women's utilization of healthcare in the Middle East and potentially the healthcare systems with a large number of Middle Eastern female immigrants around the globe: educational factors such as awareness campaigns and patient education, and personal barriers like fear and cultural norms. Moreover, Telehealth, particularly mHealth, was suggested to enhance women's participation and utilization of healthcare services. Further research is needed to explore this assertion with greater precision.

目标2030 年可持续发展议程强调在医疗保健服务中采用女权主义方法。文化和宗教影响影响着中东穆斯林妇女对医疗保健服务的利用,从而带来了独特的挑战。本文旨在调查影响中东地区妇女利用医疗保健服务的因素:在 2024 年进行了一次系统性回顾。为此检索了 PubMed、Scopus、ProQuest 和 Cochrane 系统综述数据库。采用准确性、覆盖面、客观性、日期、重要性(ACODS)核对表对收录文章的质量进行了评估。随后,采用乔菲主题分析法对综述中获得的数据进行了分析:结果:最终选定 59 项研究纳入研究范围。这些研究的质量较高,其中存在的偏倚风险被认为是可以接受的。专题分析揭示了七个主要专题,包括人口因素、教育和认识水平、信息来源、风险因素、个人因素、服务获取和质量水平以及组织因素:本研究强调了影响中东妇女利用医疗保健的关键因素,以及可能影响全球拥有大量中东女性移民的医疗保健系统的关键因素:教育因素(如宣传活动和患者教育)以及个人障碍(如恐惧和文化规范)。此外,远程保健,尤其是移动保健,被认为可以提高妇女对医疗保健服务的参与和利用。要更准确地探讨这一论断,还需要进一步的研究。
{"title":"A systematic review on factors influencing Middle Eastern women's utilization of healthcare services: The promise of mHealth.","authors":"Mohsen Khosravi, Seyyed Morteza Mojtabaeian, Mina Aghamaleki Sarvestani","doi":"10.1177/20503121241276678","DOIUrl":"10.1177/20503121241276678","url":null,"abstract":"<p><strong>Objectives: </strong>The 2030 Sustainable Development Agenda stresses a feminist approach for healthcare services. Cultural and religious influences impact utilization of healthcare services by Muslim women within the Middle East, posing unique challenges. This paper aimed to investigate the factors influencing Middle Eastern women's utilization of healthcare services within the region.</p><p><strong>Methods: </strong>In the year 2024, a systematic review was conducted. PubMed, Scopus, ProQuest, and the Cochrane Database of Systematic Reviews were searched for this purpose. The quality of the included articles was assessed using the Accuracy, Coverage, Objectivity, Date, Significance (ACODS) checklist. Subsequently, the Joffe method of thematic analysis was employed to analyze the data obtained from the review.</p><p><strong>Results: </strong>A final selection comprising 59 studies was made for inclusion in the research. The studies demonstrated a high level of quality, and the risk of bias within them was deemed acceptable. The thematic analysis revealed seven principal themes, which encompassed Demographic Factors, Level of Education and Awareness, Sources of Information, Risk Factors, Personal Factors, Level of Service Access and Quality, and Organizational Factors.</p><p><strong>Conclusions: </strong>This study highlighted key factors influencing women's utilization of healthcare in the Middle East and potentially the healthcare systems with a large number of Middle Eastern female immigrants around the globe: educational factors such as awareness campaigns and patient education, and personal barriers like fear and cultural norms. Moreover, Telehealth, particularly mHealth, was suggested to enhance women's participation and utilization of healthcare services. Further research is needed to explore this assertion with greater precision.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harmony unveiled: Intricate the interplay of dietary factor, gut microbiota, and colorectal cancer-A narrative review. 和谐揭幕:饮食因素、肠道微生物群与结直肠癌之间错综复杂的相互作用--叙述性综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241274724
Hiwot Tezera Endale, Winta Tesfaye, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Elizabeth Yihune Temesgen, Yadelew Yimer Shibabaw, Tseganesh Asefa

Diet plays a critical role in shaping the gut microbiome, which in turn regulates molecular activities in the colonic mucosa. The state and composition of the gut microbiome are key factors in the development of colorectal cancer. An altered gut microbiome, linked to weakened immune responses and the production of carcinogenic substances, is a significant contributor to colorectal cancer pathogenesis. Dietary changes that involve low-fiber and phytomolecule intake, coupled with higher consumption of red meat, can raise the risk of colorectal cancer. Salutary filaments, which reach the colon undigested, are metabolized by the gut microbiome, producing short-chain fatty acids. Short-chain fatty acids possess beneficial anti-inflammatory and antiproliferative properties that promote colon health. A well-balanced microbiome, supported by beneficial fibers and phytochemicals, can regulate the activation of proto-oncogenes and oncogenic pathways, thereby reducing cell proliferation. Recent research suggests that an overabundance of specific microbes, such as Fusobacterium nucleatum, may contribute to adverse changes in the colonic mucosa. Positive lifestyle adjustments have been demonstrated to effectively inhibit the growth of harmful opportunistic organisms. Synbiotics, which combine probiotics and prebiotics, can protect the intestinal mucosa by enhancing immune responses and decreasing the production of harmful metabolites, oxidative stress, and cell proliferation. This narrative review provides a concise understanding of evolving evidence regarding how diet influences the gut microbiome, leading to the restoration of the colonic epithelium. It underscores the importance of a healthy, plant-based diet and associated supplements in preventing colorectal cancer by enhancing gut microbiome health.

饮食在塑造肠道微生物群方面起着至关重要的作用,而肠道微生物群又反过来调节结肠粘膜的分子活动。肠道微生物群的状态和组成是结直肠癌发病的关键因素。肠道微生物群的改变与免疫反应减弱和致癌物质的产生有关,是导致结直肠癌发病的重要因素。低纤维和植物大分子摄入量的饮食变化,加上红肉摄入量的增加,会增加罹患结直肠癌的风险。未经消化进入结肠的膳食纤维会被肠道微生物群代谢,产生短链脂肪酸。短链脂肪酸具有有益的抗炎和抗增生特性,可促进结肠健康。在有益纤维和植物化学物质的支持下,平衡的微生物群可以调节原癌基因和致癌途径的活化,从而减少细胞增殖。最新研究表明,特定微生物(如核酸镰刀菌)的过度繁殖可能会导致结肠粘膜发生不良变化。事实证明,积极调整生活方式能有效抑制有害机会性微生物的生长。益生菌和益生元相结合的复合益生菌可通过增强免疫反应、减少有害代谢物的产生、氧化应激和细胞增殖来保护肠粘膜。本综述简要介绍了有关饮食如何影响肠道微生物组并导致结肠上皮恢复的证据。它强调了以植物为基础的健康饮食和相关补充剂通过增强肠道微生物组健康来预防结直肠癌的重要性。
{"title":"Harmony unveiled: Intricate the interplay of dietary factor, gut microbiota, and colorectal cancer-A narrative review.","authors":"Hiwot Tezera Endale, Winta Tesfaye, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Elizabeth Yihune Temesgen, Yadelew Yimer Shibabaw, Tseganesh Asefa","doi":"10.1177/20503121241274724","DOIUrl":"10.1177/20503121241274724","url":null,"abstract":"<p><p>Diet plays a critical role in shaping the gut microbiome, which in turn regulates molecular activities in the colonic mucosa. The state and composition of the gut microbiome are key factors in the development of colorectal cancer. An altered gut microbiome, linked to weakened immune responses and the production of carcinogenic substances, is a significant contributor to colorectal cancer pathogenesis. Dietary changes that involve low-fiber and phytomolecule intake, coupled with higher consumption of red meat, can raise the risk of colorectal cancer. Salutary filaments, which reach the colon undigested, are metabolized by the gut microbiome, producing short-chain fatty acids. Short-chain fatty acids possess beneficial anti-inflammatory and antiproliferative properties that promote colon health. A well-balanced microbiome, supported by beneficial fibers and phytochemicals, can regulate the activation of proto-oncogenes and oncogenic pathways, thereby reducing cell proliferation. Recent research suggests that an overabundance of specific microbes, such as <i>Fusobacterium nucleatum</i>, may contribute to adverse changes in the colonic mucosa. Positive lifestyle adjustments have been demonstrated to effectively inhibit the growth of harmful opportunistic organisms. Synbiotics, which combine probiotics and prebiotics, can protect the intestinal mucosa by enhancing immune responses and decreasing the production of harmful metabolites, oxidative stress, and cell proliferation. This narrative review provides a concise understanding of evolving evidence regarding how diet influences the gut microbiome, leading to the restoration of the colonic epithelium. It underscores the importance of a healthy, plant-based diet and associated supplements in preventing colorectal cancer by enhancing gut microbiome health.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The presence of animals in hospital facilities: A preliminary study on the opinion of doctors, healthcare workers, and students in Sardinia. 动物在医院设施中的存在:关于撒丁岛医生、医护人员和学生意见的初步研究。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275230
Eraldo Sanna Passino, Sara Sechi, Alessandra Mollica, Fabrizio Demaria, Raffaella Cocco

Introduction: Contact with pets within healthcare settings is considered worldwide an added value to assistance both in the case of animal-assisted interventions and also when pets are visiting hospitalized owners, due to the special emotional relationship between them and their pets. The goal of this work was to analyze local experiences on access of pets to healthcare facilities using a survey sent to doctors, veterinarians, and students in the region of Sardinia (Italy).

Methods: The online survey consisted of 17 questions, with the objective to evaluate knowledge and interest of study participants on some aspects of human-animal interaction with particular reference to potential access of pets to hospitals facilities and nursing homes and to promote an initial social judgment in the medical and healthcare environment. A total of 2484 subjects were invited to participate to the survey through an email explaining the purpose of the study. Statistical analysis on the survey results was conducted by comparing the characteristics of respondents with their answers to animal-assisted-intervention-related questions.

Results: Results showed that over 70% of the participants owned an animal; almost 80% of responses showed that survey participants were in favor of animal presence in hospitals; furthermore, the responses showed how the concept of One Health seems not only scarcely established, but also barely known. The large majority of respondents (over 80%) positively responded on questions around the role of animals as co-therapists.

Conclusions: On the one hand, this study showed lack of knowledge on the concept of One Health, whose essence is too often unknown and, on the other hand, it confirmed that women may be more inclined to show empathy and sensitivity toward animals. Regarding the profession, students seem more concerned about the introduction of animals into hospitals than healthcare workers.

导言:在世界范围内,与宠物在医疗机构中的接触被认为是一种额外的援助价值,无论是在动物辅助干预的情况下,还是在宠物探望住院的主人时,都是如此,因为主人与宠物之间有着特殊的情感关系。这项工作的目的是通过向撒丁岛(意大利)地区的医生、兽医和学生发送调查问卷,分析当地在宠物进入医疗机构方面的经验:在线调查包括 17 个问题,目的是评估研究参与者对人与动物互动某些方面的知识和兴趣,尤其是宠物可能进入医院设施和疗养院的情况,并促进对医疗保健环境的初步社会判断。研究人员通过电子邮件向 2484 名受试者解释了研究目的,并邀请他们参与调查。通过比较受访者的特征及其对动物辅助干预相关问题的回答,对调查结果进行了统计分析:结果显示,超过 70% 的参与者拥有动物;近 80% 的回答显示,调查参与者赞成动物在医院中的存在;此外,回答还显示,"一体健康 "的概念似乎不仅尚未确立,而且也鲜为人知。绝大多数受访者(超过 80%)都对动物作为合作治疗师的作用做出了积极回应:一方面,这项研究表明,人们对 "一体健康 "概念缺乏了解,其本质往往不为人知;另一方面,研究证实,女性可能更倾向于对动物表现出同情和敏感。在职业方面,学生似乎比医护人员更关心将动物引入医院的问题。
{"title":"The presence of animals in hospital facilities: A preliminary study on the opinion of doctors, healthcare workers, and students in Sardinia.","authors":"Eraldo Sanna Passino, Sara Sechi, Alessandra Mollica, Fabrizio Demaria, Raffaella Cocco","doi":"10.1177/20503121241275230","DOIUrl":"10.1177/20503121241275230","url":null,"abstract":"<p><strong>Introduction: </strong>Contact with pets within healthcare settings is considered worldwide an added value to assistance both in the case of animal-assisted interventions and also when pets are visiting hospitalized owners, due to the special emotional relationship between them and their pets. The goal of this work was to analyze local experiences on access of pets to healthcare facilities using a survey sent to doctors, veterinarians, and students in the region of Sardinia (Italy).</p><p><strong>Methods: </strong>The online survey consisted of 17 questions, with the objective to evaluate knowledge and interest of study participants on some aspects of human-animal interaction with particular reference to potential access of pets to hospitals facilities and nursing homes and to promote an initial social judgment in the medical and healthcare environment. A total of 2484 subjects were invited to participate to the survey through an email explaining the purpose of the study. Statistical analysis on the survey results was conducted by comparing the characteristics of respondents with their answers to animal-assisted-intervention-related questions.</p><p><strong>Results: </strong>Results showed that over 70% of the participants owned an animal; almost 80% of responses showed that survey participants were in favor of animal presence in hospitals; furthermore, the responses showed how the concept of One Health seems not only scarcely established, but also barely known. The large majority of respondents (over 80%) positively responded on questions around the role of animals as co-therapists.</p><p><strong>Conclusions: </strong>On the one hand, this study showed lack of knowledge on the concept of One Health, whose essence is too often unknown and, on the other hand, it confirmed that women may be more inclined to show empathy and sensitivity toward animals. Regarding the profession, students seem more concerned about the introduction of animals into hospitals than healthcare workers.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccine-associated vasculitis: A systematic review. COVID-19 疫苗相关性血管炎:系统综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241261165
Aseel Abuhammad, Maram Albandak, Mohammed Ayyad, Eman Refayeh, Basema Qawasma, Shaima Hour, Yazan Abu Thraiee, Zaid A Sowaity, Osama Dukmak, Afnan W M Jobran, Laith Alamleh

Objectives: Post-COVID-19 vaccine-associated vasculitis stands as one of the most serious side effects attributed to COVID-19 vaccines. This complication encompasses diverse manifestations which vary in presentation and severity. Moreover, it can impact patients across all age groups, with a notably elevated incidence in the elderly. This systematic review seeks to review and evaluate the spectrum of vasculitis manifestations linked to COVID-19 vaccination.

Methods: A systematic review of the literature was done by searching through PubMed, Google Scholar, and Scopus up to October 2022. Articles including data about sex, age at diagnosis, vasculitis clinical manifestations, type of vaccination, most commonly used investigations, comorbid medical conditions, treatments, and clinical outcomes were included in the final analysis. Furthermore, vasculitis flare-ups post-vaccination were considered part of this review.

Results: A total number of 117 studies describing 158 patients developing vasculitis following COVID-19 vaccination were included in the final analysis. Among the patients who developed vasculitis, the most administered type of vaccination was the mRNA vaccine subtype (n = 103), followed by the viral vector vaccines (n = 42) and inactivated viral vaccines (n = 10). On the other hand, about 38% of vasculitis-related symptoms occurred after the administration of the first dose of the vaccine and 37% occurred after taking the second dose. The skin (60.7%) and the kidneys (27.8%) were the most affected organs and complete remission was achieved in 111 patients (70%), while partial remission occurred in 11% of the patient population.

Conclusion: COVID-19 vaccine-induced vasculitis is a rare occurrence associated with COVID-19 vaccines. It generally presents a favorable prognosis and outcomes for the vast majority of patients, ultimately leading to full remission within days. This review emphasizes the notion that the advantages of COVID-19 vaccines outweigh the potential risks, particularly for individuals with compromised immune systems.

目标:COVID-19 疫苗接种后相关血管炎是 COVID-19 疫苗最严重的副作用之一。这种并发症包括多种表现形式,其表现形式和严重程度各不相同。此外,它可影响所有年龄组的患者,尤其是老年人的发病率较高。本系统综述旨在回顾和评估与接种 COVID-19 疫苗相关的血管炎表现:通过搜索 PubMed、Google Scholar 和 Scopus,对截至 2022 年 10 月的文献进行了系统综述。最终分析纳入的文章包括性别、诊断年龄、血管炎临床表现、疫苗接种类型、最常用的检查方法、合并症、治疗方法和临床结果等数据。此外,接种疫苗后脉管炎复发也被视为本次综述的一部分:结果:共有 117 项研究纳入了最终分析,这些研究描述了 158 名接种 COVID-19 疫苗后出现血管炎的患者。在发生血管炎的患者中,接种最多的疫苗类型是 mRNA 疫苗亚型(103 例),其次是病毒载体疫苗(42 例)和灭活病毒疫苗(10 例)。另一方面,约 38% 的血管炎相关症状发生在接种第一剂疫苗后,37% 发生在接种第二剂疫苗后。皮肤(60.7%)和肾脏(27.8%)是受影响最严重的器官,111名患者(70%)的病情完全缓解,11%的患者病情部分缓解:结论:COVID-19疫苗诱发的血管炎是一种与COVID-19疫苗相关的罕见病。结论:COVID-19 疫苗诱发的血管炎是与 COVID-19 疫苗相关的罕见病症,一般来说,绝大多数患者的预后和治疗效果良好,最终可在数天内完全缓解。本综述强调 COVID-19 疫苗的优势大于潜在风险,尤其是对于免疫系统受损的患者。
{"title":"COVID-19 vaccine-associated vasculitis: A systematic review.","authors":"Aseel Abuhammad, Maram Albandak, Mohammed Ayyad, Eman Refayeh, Basema Qawasma, Shaima Hour, Yazan Abu Thraiee, Zaid A Sowaity, Osama Dukmak, Afnan W M Jobran, Laith Alamleh","doi":"10.1177/20503121241261165","DOIUrl":"10.1177/20503121241261165","url":null,"abstract":"<p><strong>Objectives: </strong>Post-COVID-19 vaccine-associated vasculitis stands as one of the most serious side effects attributed to COVID-19 vaccines. This complication encompasses diverse manifestations which vary in presentation and severity. Moreover, it can impact patients across all age groups, with a notably elevated incidence in the elderly. This systematic review seeks to review and evaluate the spectrum of vasculitis manifestations linked to COVID-19 vaccination.</p><p><strong>Methods: </strong>A systematic review of the literature was done by searching through PubMed, Google Scholar, and Scopus up to October 2022. Articles including data about sex, age at diagnosis, vasculitis clinical manifestations, type of vaccination, most commonly used investigations, comorbid medical conditions, treatments, and clinical outcomes were included in the final analysis. Furthermore, vasculitis flare-ups post-vaccination were considered part of this review.</p><p><strong>Results: </strong>A total number of 117 studies describing 158 patients developing vasculitis following COVID-19 vaccination were included in the final analysis. Among the patients who developed vasculitis, the most administered type of vaccination was the mRNA vaccine subtype (<i>n</i> = 103), followed by the viral vector vaccines (<i>n</i> = 42) and inactivated viral vaccines (<i>n</i> = 10). On the other hand, about 38% of vasculitis-related symptoms occurred after the administration of the first dose of the vaccine and 37% occurred after taking the second dose. The skin (60.7%) and the kidneys (27.8%) were the most affected organs and complete remission was achieved in 111 patients (70%), while partial remission occurred in 11% of the patient population.</p><p><strong>Conclusion: </strong>COVID-19 vaccine-induced vasculitis is a rare occurrence associated with COVID-19 vaccines. It generally presents a favorable prognosis and outcomes for the vast majority of patients, ultimately leading to full remission within days. This review emphasizes the notion that the advantages of COVID-19 vaccines outweigh the potential risks, particularly for individuals with compromised immune systems.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heartware ventricular assist device versus HeartMate II versus HeartMate III in advanced heart failure patients: A systematic review and meta-analysis. 在晚期心力衰竭患者中,Heartware 心室辅助装置与 HeartMate II 和 HeartMate III 的比较:系统回顾和荟萃分析。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241278226
Dudy Arman Hanafy, Theresia Feline Husen, Ruth Angelica, Ilona Nathania, Widya Trianita Suwatri, Pasati Lintangella, Wahyu Prima Erdianto, Prisillia Prasetyo

Objective: Ventricular assist device is one of the treatment options for heart failure patients. Therefore, the purpose of this review is to aid in clinical decision-making of exchanging previous older ventricular assist device models to the newest one, HM3.

Methods: The search was conducted across several databases until February 25, 2023, and was registered with the ID of CRD42023405367. Risk of bias was performed using Cochrane Risk of Bias 2.0 and the Newcastle Ottawa Scale. In order to rank and evaluate the pooled odds ratios and mean differences with 95% confidence intervals, we employed conventional and Bayesian network meta-analysis converted to surface under the cumulative ranking.

Results: A total of 49 studies with 31,105 patients were included in this review. HM3 is the best device exchange choice that causes the lowest risk of mortality (HM3 (99.98) > HM2 (32.43) > HVAD (17.58)), cerebrovascular accidents (HM3 (99.99) > HM2 (42.41) > HVAD (7.60)), other neurologic events beside cerebrovascular accident (HM3 (91.45) > HM2 (54.16) > HVAD (4.39)), pump thrombosis (HM3 (100.00) > HM2 (39.20) > HVAD (10.80)), and bleeding (HM3 (97.12) > HM2 (47.60) > HVAD (5.28)). HM3 is also better than HM2 in hospital admissions (OR: 1.90 (95% CI: 1.15-3.12)). When complications were present, HM2 or Heartware ventricular assist devices exchange to HM3 lowered the mortality rate compared to exchanging it to the same device type.

Conclusion: HM3 is the best device for all six outcomes. Exchange from Heartware ventricular assist devices or HM2 to HM3 rather than the same ventricular assist device type is recommended only if a complication is present.

目的:心室辅助装置是心衰患者的治疗选择之一。因此,本综述旨在帮助临床决定是否将以前的旧型心室辅助装置更换为最新型的 HM3:在 2023 年 2 月 25 日之前,在多个数据库中进行了检索,注册 ID 为 CRD42023405367。使用 Cochrane Risk of Bias 2.0 和纽卡斯尔-渥太华量表进行偏倚风险分析。为了对汇集的几率比和均值差异及95%置信区间进行排序和评估,我们采用了传统的贝叶斯网络荟萃分析法,并将其转换为累积排序下的表面分析法:本综述共纳入了 49 项研究,31105 名患者。HM3 是最佳的设备交换选择,其导致的死亡率(HM3(99.98)> HM2(32.43)> HVAD(17.58))、脑血管意外(HM3(99.99)> HM2(42.41)> HVAD(7.60))、脑血管意外以外的其他神经事件(HM3(91.45)> HM2(54.16)> HVAD(4.39))、泵血栓(HM3(100.00)> HM2(39.20)> HVAD(10.80))和出血(HM3(97.12)> HM2(47.60)> HVAD(5.28))。在入院率方面,HM3 也优于 HM2(OR:1.90(95% CI:1.15-3.12))。当出现并发症时,将HM2或Heartware心室辅助装置更换为HM3与更换为相同类型的装置相比,死亡率更低:结论:就所有六种结果而言,HM3 是最佳设备。只有在出现并发症时,才建议将 Heartware 心室辅助装置或 HM2 换成 HM3,而不是换成相同类型的心室辅助装置。
{"title":"Heartware ventricular assist device versus HeartMate II versus HeartMate III in advanced heart failure patients: A systematic review and meta-analysis.","authors":"Dudy Arman Hanafy, Theresia Feline Husen, Ruth Angelica, Ilona Nathania, Widya Trianita Suwatri, Pasati Lintangella, Wahyu Prima Erdianto, Prisillia Prasetyo","doi":"10.1177/20503121241278226","DOIUrl":"10.1177/20503121241278226","url":null,"abstract":"<p><strong>Objective: </strong>Ventricular assist device is one of the treatment options for heart failure patients. Therefore, the purpose of this review is to aid in clinical decision-making of exchanging previous older ventricular assist device models to the newest one, HM3.</p><p><strong>Methods: </strong>The search was conducted across several databases until February 25, 2023, and was registered with the ID of CRD42023405367. Risk of bias was performed using Cochrane Risk of Bias 2.0 and the Newcastle Ottawa Scale. In order to rank and evaluate the pooled odds ratios and mean differences with 95% confidence intervals, we employed conventional and Bayesian network meta-analysis converted to surface under the cumulative ranking.</p><p><strong>Results: </strong>A total of 49 studies with 31,105 patients were included in this review. HM3 is the best device exchange choice that causes the lowest risk of mortality (HM3 (99.98) > HM2 (32.43) > HVAD (17.58)), cerebrovascular accidents (HM3 (99.99) > HM2 (42.41) > HVAD (7.60)), other neurologic events beside cerebrovascular accident (HM3 (91.45) > HM2 (54.16) > HVAD (4.39)), pump thrombosis (HM3 (100.00) > HM2 (39.20) > HVAD (10.80)), and bleeding (HM3 (97.12) > HM2 (47.60) > HVAD (5.28)). HM3 is also better than HM2 in hospital admissions (OR: 1.90 (95% CI: 1.15-3.12)). When complications were present, HM2 or Heartware ventricular assist devices exchange to HM3 lowered the mortality rate compared to exchanging it to the same device type.</p><p><strong>Conclusion: </strong>HM3 is the best device for all six outcomes. Exchange from Heartware ventricular assist devices or HM2 to HM3 rather than the same ventricular assist device type is recommended only if a complication is present.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicare skilled nursing facilities' occupancy and payer source: The moderating role of financial performance. 医疗保险专业护理机构的入住率与付款人来源:财务业绩的调节作用。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275368
Hyunmin Kim, Asos Mahmood, Cyril F Chang, Aram Dobalian

Objectives: While extensive research has focused on patient outcomes in skilled nursing facilities, a critical gap remains in understanding factors influencing their managerial performance, particularly occupancy rates. This study examines the occupancy rates of skilled nursing facilities and assesses the significance of two important drivers of managerial performance that have not received sufficient attention-the influence of payer mix and total profit margin. Specifically, we focused on the role played by a nursing home's financial performance (as assessed by profit margin) in influencing the relationship between payer mix and occupancy rate among skilled nursing facilities.

Methods: Data were extracted from the 2019 to 2020 Joint Annual Report of Nursing Homes for a sample of 612 skilled nursing facilities in Tennessee, USA. Regression analysis was performed by fitting a generalized estimating equation of occupancy rate.

Results: Compared to skilled nursing facilities in the lowest quartile of profit margin, for example, those in the highest quartile had approximately 18 percentage points higher occupancy rates per unit increase in resident days of care covered by traditional Medicare (β = 0.18, p = 0.0028). Similarly, skilled nursing facilities in the second highest quartile of profit margin had a higher occupancy rate by approximately 23 percentage points per unit increase in Medicare Advantage (β = 0.23, p = 0.0375) when compared to those in the lowest quartile of profit margin.

Conclusions: Skilled nursing facilities with stronger financial performance generally have higher occupancy rates, particularly notable in relation to an upswing in payer sources such as traditional Medicare and Medicare Advantage, when compared to skilled nursing facilities with weaker profitability. Given the increasingly larger role of Medicare in long-term care funding, policymakers and nursing home managers may find it useful to consider our findings when evaluating opportunities to enhance managerial performance of skilled nursing facilities.

目标:虽然对专业护理机构的患者治疗效果进行了广泛的研究,但在了解影响其管理绩效的因素(尤其是入住率)方面仍存在重大差距。本研究考察了专业护理机构的入住率,并评估了尚未引起足够重视的管理绩效的两个重要驱动因素--支付方组合和总利润率的影响。具体来说,我们重点研究了疗养院的财务绩效(以利润率评估)在影响支付方组合与专业护理机构入住率之间关系方面所发挥的作用:从美国田纳西州 612 家专业护理机构的《2019 至 2020 年养老院联合年度报告》中提取数据。通过拟合入住率的广义估计方程进行回归分析:例如,与利润率处于最低四分位数的专业护理机构相比,处于最高四分位数的专业护理机构的入住率比传统医疗保险覆盖的居民护理天数每增加一个单位高出约 18 个百分点(β = 0.18,p = 0.0028)。同样,与利润率处于最低四分位数的机构相比,利润率处于第二高四分位数的专业护理机构的入住率要高出约 23 个百分点(β = 0.23,p = 0.0375):与盈利能力较弱的专业护理机构相比,财务状况较好的专业护理机构一般具有较高的入住率,尤其是在传统医疗保险和医疗保险优势等支付来源上升的情况下。鉴于医疗保险在长期护理资金中扮演着越来越重要的角色,政策制定者和疗养院管理者在评估提高专业护理机构管理绩效的机会时,不妨考虑一下我们的研究结果。
{"title":"Medicare skilled nursing facilities' occupancy and payer source: The moderating role of financial performance.","authors":"Hyunmin Kim, Asos Mahmood, Cyril F Chang, Aram Dobalian","doi":"10.1177/20503121241275368","DOIUrl":"10.1177/20503121241275368","url":null,"abstract":"<p><strong>Objectives: </strong>While extensive research has focused on patient outcomes in skilled nursing facilities, a critical gap remains in understanding factors influencing their managerial performance, particularly occupancy rates. This study examines the occupancy rates of skilled nursing facilities and assesses the significance of two important drivers of managerial performance that have not received sufficient attention-the influence of payer mix and total profit margin. Specifically, we focused on the role played by a nursing home's financial performance (as assessed by profit margin) in influencing the relationship between payer mix and occupancy rate among skilled nursing facilities.</p><p><strong>Methods: </strong>Data were extracted from the 2019 to 2020 Joint Annual Report of Nursing Homes for a sample of 612 skilled nursing facilities in Tennessee, USA. Regression analysis was performed by fitting a generalized estimating equation of occupancy rate.</p><p><strong>Results: </strong>Compared to skilled nursing facilities in the lowest quartile of profit margin, for example, those in the highest quartile had approximately 18 percentage points higher occupancy rates per unit increase in resident days of care covered by traditional Medicare (β = 0.18, <i>p</i> = 0.0028). Similarly, skilled nursing facilities in the second highest quartile of profit margin had a higher occupancy rate by approximately 23 percentage points per unit increase in Medicare Advantage (β = 0.23, <i>p</i> = 0.0375) when compared to those in the lowest quartile of profit margin.</p><p><strong>Conclusions: </strong>Skilled nursing facilities with stronger financial performance generally have higher occupancy rates, particularly notable in relation to an upswing in payer sources such as traditional Medicare and Medicare Advantage, when compared to skilled nursing facilities with weaker profitability. Given the increasingly larger role of Medicare in long-term care funding, policymakers and nursing home managers may find it useful to consider our findings when evaluating opportunities to enhance managerial performance of skilled nursing facilities.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review. 射频识别技术;一种分析伪造药品的方法:文献综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272725
Minichil Chanie Worku, Melaku Getahun Feleke, Tewodros Denekew, Yeniewa Kerie Anagaw

Quality has been a concern of the World Health Organization since its inception and is defined as fitness for use. Since our ancestors began trading several millennia ago, Falsified Pharmaceutical Products has been a recurring problem and still threatens economic stability and public health. Its definition various from country to country and according to World Health Organization, 2017, it is 'a product that is deliberately and fraudulently mislabelled with respect to identity and/or source'. The implementation of anti-falsified nanomaterial technologies is the prominent preventive measure to track and/or detect Falsified Pharmaceutical Products. Software and hardware companies had made encouraging progress towards implementing Radio Frequency Identification devices for ensuring the authenticity of pharmaceutical products. The purpose of the review was to critically appraise Radio Frequency Identification devices technology for the purpose of track and trace Falsified Pharmaceutical Products circulating in the market. Different search engines such as Google Scholar, Science Direct and PubMed were applied and mesh terms and keywords were searched. Different guides and related books were investigated in addition to the articles. Radio Frequency Identification devices technology is a compact electronic device that contains a small chip and reader with antenna that enables wireless transmission of identity of pharmaceutical products. The authenticated Radio Frequency Identification devices model is used for pharmaceutical products' authentication from origin of pharmaceutical industry to the pharmacy at any point along the chain of the distribution. Popular pharmaceutical products, such as OxyContin and Sildenafil Citrate, which are particular targets of falsification have mandated the use of Radio Frequency Identification devices technology.

自世界卫生组织成立以来,质量一直是其关注的问题,质量的定义是适合使用。自几千年前我们的祖先开始从事贸易以来,掺假药品一直是一个反复出现的问题,至今仍威胁着经济稳定和公众健康。各国对它的定义不尽相同,根据世界卫生组织 2017 年的定义,它是 "一种在身份和/或来源方面故意和欺诈性地贴错标签的产品"。采用反掺假纳米材料技术是追踪和/或检测掺假医药产品的主要预防措施。软件和硬件公司在采用射频识别装置确保药品真实性方面取得了令人鼓舞的进展。本综述旨在对射频识别设备技术进行严格评估,以跟踪和追查市场上流通的假药。我们使用了不同的搜索引擎,如 Google Scholar、Science Direct 和 PubMed,并搜索了网格术语和关键词。除文章外,还调查了不同的指南和相关书籍。射频识别设备技术是一种紧凑型电子设备,包含一个小型芯片和带有天线的读取器,可以无线传输药品的身份信息。经认证的射频识别设备模型可用于医药产品从制药业原产地到药房销售链条上任何一个环节的认证。奥施康定(OxyContin)和枸橼酸西地那非(Sildenafil Citrate)等热门药品是特别容易被伪造的目标,因此已强制要求使用射频识别设备技术。
{"title":"Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review.","authors":"Minichil Chanie Worku, Melaku Getahun Feleke, Tewodros Denekew, Yeniewa Kerie Anagaw","doi":"10.1177/20503121241272725","DOIUrl":"10.1177/20503121241272725","url":null,"abstract":"<p><p>Quality has been a concern of the World Health Organization since its inception and is defined as fitness for use. Since our ancestors began trading several millennia ago, Falsified Pharmaceutical Products has been a recurring problem and still threatens economic stability and public health. Its definition various from country to country and according to World Health Organization, 2017, it is 'a product that is deliberately and fraudulently mislabelled with respect to identity and/or source'. The implementation of anti-falsified nanomaterial technologies is the prominent preventive measure to track and/or detect Falsified Pharmaceutical Products. Software and hardware companies had made encouraging progress towards implementing Radio Frequency Identification devices for ensuring the authenticity of pharmaceutical products. The purpose of the review was to critically appraise Radio Frequency Identification devices technology for the purpose of track and trace Falsified Pharmaceutical Products circulating in the market. Different search engines such as Google Scholar, Science Direct and PubMed were applied and mesh terms and keywords were searched. Different guides and related books were investigated in addition to the articles. Radio Frequency Identification devices technology is a compact electronic device that contains a small chip and reader with antenna that enables wireless transmission of identity of pharmaceutical products. The authenticated Radio Frequency Identification devices model is used for pharmaceutical products' authentication from origin of pharmaceutical industry to the pharmacy at any point along the chain of the distribution. Popular pharmaceutical products, such as OxyContin and Sildenafil Citrate, which are particular targets of falsification have mandated the use of Radio Frequency Identification devices technology.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19. COVID 19 大流行对神经内科住院治疗的影响,分析继发于 COVID 19 和接种 COVID 19 疫苗的神经系统并发症。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-28 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241272518
Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, Yuhei Anan, Tadashi Ozawa, Reiji Koide, Ryota Tanaka, Akio Kimura, Shigeru Fujimoto

Objective: We investigated the effect of the pandemic on neurological hospitalizations and complications associated with severe acute respiratory syndrome coronavirus 2 infection or vaccinations.

Methods: We retrospectively analyzed data of patients hospitalized in our neurology division from 1 April 2019 to 31 March 2022 as the opt-out study. We classified the neurological diseases into nine subgroups, evaluated changes of neurological disease characteristics, and analyzed patients hospitalized with the complications from severe acute respiratory syndrome coronavirus 2 infection or after the coronavirus disease 2019 vaccination over three eras based on the pandemic stages: (1) pre-pandemic, (2) during the pandemic but before vaccines, and (3) during the pandemic with vaccines.

Results: Overall, 1756 patients were included in the analyses. The patient characteristics significantly changed throughout the pandemic (p < 0.01). Although the number of autoimmune cases did not change throughout the pandemic (p = 0.53), that of psychological cases and that of unknown cases were significantly changed (p < 0.05, p < 0.01). There were four infectious cases and 11 cases following vaccination from 1 April 2020 to 31 March 2022. The 11 postvaccination cases involved 10 kinds of neurological diseases.

Conclusions: The neurological characteristics significantly changed throughout the pandemic and there were diverse neurological complications following vaccinations.

目的我们调查了大流行对神经科住院患者的影响以及与严重急性呼吸系统综合征冠状病毒 2 感染或疫苗接种相关的并发症:我们回顾性分析了2019年4月1日至2022年3月31日在我院神经内科住院的患者数据,作为选择退出研究。我们将神经系统疾病分为九个亚组,评估了神经系统疾病特征的变化,并根据大流行阶段分析了三个时期因严重急性呼吸系统综合征冠状病毒 2 感染并发症或接种冠状病毒病 2019 年疫苗后住院的患者:(1) 大流行前;(2) 大流行期间但疫苗接种前;(3) 大流行期间接种疫苗后:共有 1756 名患者参与了分析。在整个大流行期间,患者的特征发生了明显变化(P P = 0.53),心理病例和未知病例的特征发生了明显变化(P P 结论):在整个大流行期间,神经系统特征发生了明显变化,接种疫苗后出现了多种神经系统并发症。
{"title":"Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19.","authors":"Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, Yuhei Anan, Tadashi Ozawa, Reiji Koide, Ryota Tanaka, Akio Kimura, Shigeru Fujimoto","doi":"10.1177/20503121241272518","DOIUrl":"10.1177/20503121241272518","url":null,"abstract":"<p><strong>Objective: </strong>We investigated the effect of the pandemic on neurological hospitalizations and complications associated with severe acute respiratory syndrome coronavirus 2 infection or vaccinations.</p><p><strong>Methods: </strong>We retrospectively analyzed data of patients hospitalized in our neurology division from 1 April 2019 to 31 March 2022 as the opt-out study. We classified the neurological diseases into nine subgroups, evaluated changes of neurological disease characteristics, and analyzed patients hospitalized with the complications from severe acute respiratory syndrome coronavirus 2 infection or after the coronavirus disease 2019 vaccination over three eras based on the pandemic stages: (1) pre-pandemic, (2) during the pandemic but before vaccines, and (3) during the pandemic with vaccines.</p><p><strong>Results: </strong>Overall, 1756 patients were included in the analyses. The patient characteristics significantly changed throughout the pandemic (<i>p</i> < 0.01). Although the number of autoimmune cases did not change throughout the pandemic (<i>p</i> = 0.53), that of psychological cases and that of unknown cases were significantly changed (<i>p</i> < 0.05, <i>p</i> < 0.01). There were four infectious cases and 11 cases following vaccination from 1 April 2020 to 31 March 2022. The 11 postvaccination cases involved 10 kinds of neurological diseases.</p><p><strong>Conclusions: </strong>The neurological characteristics significantly changed throughout the pandemic and there were diverse neurological complications following vaccinations.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
SAGE Open Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1